ArticleFrontiers in oncology2022

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer.

Youzhi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.